Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Blood cholesterol and mortality].

J L Richard1, E Bruckert, F Delahaye

  • 1INSERM, U 258, hôpital Broussais, Lyon.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|October 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Team nursing.

Nursing times·1992
Same author

Lack of platelet-activating factor release during reversible myocardial ischaemia.

European heart journal·1992
Same author

[Diagnostic and therapeutic strategy in patients with multiple arterial disease].

Annales de cardiologie et d'angeiologie·1992
Same author

Risk assessment for aflatoxin B1: a modeling approach.

Risk analysis : an official publication of the Society for Risk Analysis·1992
Same author

Comparison of skin changes induced on mice by either group A type 12 or group G streptococci.

Experimental dermatology·1992
Same author

IBIS integrated biological imaging system: electron micrograph image-processing software running on Unix workstations.

Computer applications in the biosciences : CABIOS·1992
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

Serum cholesterol levels influence mortality rates, with higher levels linked to increased coronary and cerebrovascular events, while low levels correlate with non-cardiovascular and cancer mortality. Causal links require further experimental validation beyond observational data.

Area of Science:

  • Cardiovascular epidemiology
  • Biomarker analysis
  • Public health

Context:

  • Serum cholesterol is a key biomarker influencing various mortality causes.
  • Observational studies reveal complex associations between cholesterol levels and mortality.
  • Experimental data is crucial for establishing causality.

Purpose:

  • To analyze the relationship between serum cholesterol levels and mortality rates.
  • To differentiate associations from causality in cholesterol-related mortality.
  • To evaluate the implications for primary prevention strategies.

Summary:

  • Prospective studies show increased all-cause mortality at both low and high cholesterol levels.
  • Coronary heart disease mortality rises proportionally with serum cholesterol.

Related Experiment Videos

  • Low cholesterol is linked to increased non-cardiovascular, cancer, and hemorrhagic stroke mortality, while high cholesterol correlates with thrombotic stroke.

    • Impact:

    • Highlights the J-shaped curve for cholesterol and all-cause mortality.
    • Underscores the need for carefully designed trials to confirm cholesterol-lowering efficacy.
    • Informs public health guidelines on cholesterol management and cardiovascular risk assessment.